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ORIGINAL ARTICLE
Background/Aims: Although colorectal adenoma is reported to recur frequently, this may result from missing it
at baseline. However, few studies of recurrence have considered the miss rate. This study evaluated the recurrence
rate prospectively and clinical predictors of recurrence in colorectal adenoma after lowering the miss rate. 
Methods: The study population comprised 128 patients who underwent baseline colonoscopy with resection of
colorectal adenomas. Re-examination to lower the miss rate was performed within 2 months. Follow-up colonoscopy
to detect recurrence was done more than 1 year after removal.
Results: The mean follow-up period was 35.1 months (range, 12 to 84 months). Thirty patients had a recurrent
adenoma, for a recurrence rate of 23.4%. Older patients (over 60 years) had a two-fold greater risk of recurrence
than younger patients (hazard ratio, 2.39; 95% confidence interval [CI], 1.16-4.90). Patients with three or four
adenomas at baseline colonoscopy had a two-fold greater risk than those with one adenoma (hazard ratio, 2.44;
95% CI, 1.11-5.35). Patients with advanced adenoma had a two-fold greater risk than those with no advanced
adenoma (hazard ratio, 2.88; 95% CI, 1.40-5.95). In multivariate analysis, only the presence of three or four
adenomas independently predicted the recurrence of adenoma (hazard ratio, 3.19; 95% CI, 1.04-9.79).
Conclusions: The recurrence rate of colorectal adenoma corrected by lowering the miss rate was lower than
reported rates. The presence of multiple adenomas on initial colonoscopy was an important predictor of recurrence.
(Korean J Intern Med 2009;24:196-202)
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INTRODUCTION
Most colorectal cancers arise from adenomatous polyps.
Colorectal adenomas are common in the general
population. The estimated prevalence rate is 30-50% after
the age of 65 years [1-3]. The removal of adenomas is
associated with a lower risk of colorectal cancer [4,5].
However, patients with removed adenomas remain at high
risk of developing new adenomas or cancers, justifying
follow-up with repeated colonoscopies [6]. The clinical
characteristics of patients at high risk of adenoma
recurrence are controversial.
The main problem in studying adenoma recurrence is
a falsely high estimated recurrence rate due to missing
adenomas at the time of the baseline colonoscopy. The
estimated colonoscopic miss rate for polyps is 15-24%
[7-9]. Most research on adenoma recurrence and risk
factors has not considered the miss rate. Therefore, this
study evaluated the recurrence rate of colorectal adenoma
prospectively, and the clinical characteristics associated
with recurrence when the miss rate was reduced by
follow-up colonoscopy within 2 months.Ji JS, et al. Predictors of recurrence in colorectal adenoma    197
METHODS
Study population
The study enrolled 667 patients who were older than 40
years, underwent colonoscopy for the first time between
March 1997 and June 2001, and had a colorectal adenoma
or mucosal cancer that was diagnosed on pathology after
polypectomy. We excluded 119 patients with advanced
cancer, polyposis syndrome, inflammatory bowel disease,
intestinal tuberculosis, and five or more polyps. Of the
548 patients, 232 patients underwent a re-examination
to detect and remove missed adenomas within 2 months.
Ultimately, the study population comprised 128 of the
232 patients, who underwent a follow-up colonoscopy after
1 year or more.
Endoscopic procedures
Colonoscopy was performed with a standard colonoscope
(CF-Q240AL, Olympus Optical, Tokyo, Japan) by three
experienced endoscopists who had each performed more
than 500 cases annually for at least 3 years. All patients
were given a routine bowel preparation that included
the ingestion of 4 L of a balanced electrolyte solution
with polyethylene glycol 6 hours before the procedure.
The degree of bowel preparation was classified as good,
acceptable, and poor. Only good bowel preparation was
included in this study. Meperidine (50 mg) and midazolam
(3 mg) were administered to all patients just before
colonoscopy. To increase the polyp detection rate, 0.2%
indigo carmine was sprayed on suspected lesions.
Colonoscopic withdrawal was done as slowly as possible
over 6 minutes.
We analyzed the number, size, location, and morphology
of adenomatous polyps at baseline colonoscopy and the
existence of villous architecture and degree of dysplasia
on pathology. Advanced adenoma was defined as an
adenoma of diameter ≥10 mm or a villous component or
severe dysplasia. The location of the adenoma was divided
into the proximal colon (the cecum, ascending, and
transverse colon) and the distal colon (the splenic flexure,
descending colon, sigmoid colon, and rectum). For patients
with multiple adenomas, the most affected adenoma was
used to classify the size, location, morphology, and histologic
architecture. The most affected adenoma was defined as
mucosal cancer first, advanced adenoma second, and then
the largest adenoma.
The polyp miss rate was defined as the proportion of
polyps detected only during the second colonoscopy relative
to the total number of polyps found during the first and
second examinations.
Follow-up colonoscopy was performed at least 1 year
after the baseline colonoscopy to evaluate recurrent
adenomas, which were assessed according to number,
size, location, morphology, villous component, degree of
dysplasia, and existence of advanced adenoma. The
primary end point was adenoma recurrence. The annual
recurrence rate was calculated as the number of patients
with recurrent adenoma in a given year divided by the
number of patients who underwent colonoscopy in the
same period.
The study was approved by our institutional ethics
committee and written informed consent was obtained
from each patient before the procedure.
Statistical analysis
Standard procedures in the Statistical Package for the
SPSS version 11.5 (SPSS Inc., Chicago, IL, USA) were used
for the statistical analysis. Kaplan-Meier analyses with
log-rank test were used to identify univariate predictors
of adenoma recurrence. Multivariate analysis was
conducted using Cox proportional hazard model. The
importance of each independent variable was summarized
by its hazard ratio and 95% confidence interval (CI).
Kaplan-Meier curves were used to estimate the cumulative
recurrence rates, and the log-rank test was applied to
compare differences between cumulative recurrence
curves. The chi-square test was used to compare the
characteristics of baseline and recurrent adenomas and
Table 1. Miss rate of colorectal polyps according to the initial number of polyps
Number of polyps on the initial examination Total
123 4
Patients, n 83 29 7 9 128
Patients with missed polyps, n 19 11 4 7 41
Miss rate*, % 22.9 37.9 57.1 77.8 32.0
*p=0.001198 The Korean Journal of Internal Medicine Vol. 24, No. 3, September 2009
the miss rate of polyps according to the initial number and
size of polyps. A p value less than 0.05 was considered
statistically significant.
RESULTS
Baseline characteristics
Of the 128 patients, 66 were male and 62 were female.
The mean age was 55.1±0.8 years (mean±standard error
of the mean; range 40-81). The mean age of the recurrence
group was 57.5±1.4 years (range 41-71), and that of the
non-recurrence group was 54.3±0.9 years (range 40-81).
The mean follow-up period was 35.1±1.6 months (range
12-84). 
Miss rate of polyps and adenomas
During the first and second examinations, a total 250
polyps were found, 53 of which were missed. The overall
miss rate of polyps was 21.2%. The miss rate of colorectal
polyps based on the initial number of polyps is shown in
Table 1. As the number of polyps found during the initial
examination increased, the miss rate increased signifi-
cantly (p=0.001) and was 22.9, 37.9, 57.1, and 77.8% in
patients with one to four polyps, respectively. The miss
rate based on polyp size was 23.9% for 1-4 mm polyps,
19.8% for 5-9 mm polyps, and 10% for polyps ≥10 mm
(Table 2). The polyp miss rate tended to be greater with
smaller size, but the effect was not significant (p=0.159).
At the first and second examinations, a total of 214
adenomas were found, of which 38 were missed for an
overall miss rate of 17.7%. 
Adenoma recurrence rate
A total of 30 of the 128 patients had recurrent adenomas
and the recurrence rate was 23.4%. The number of
patients examined during each year of follow-up was 69,
35, 32, 24, 8, and 5 in years 1-2, 2-3, 3-4, 4-5, 5-6, and 6-7,
respectively, for respective annual recurrence rates of
27.5, 14.3, 12.5, 4.2, 0, and 20% (Fig. 1). In four patients,
the recurrence was an advanced adenoma: three were
found in year 1-2 and one in year 2-3. 
Patient characteristics associated with recurrence
The older group (over 60 years) had a two-fold greater
risk than the younger group (hazard ratio, 2.39; 95% CI,
1.16-4.90). There was no significant difference according
to sex or family history of colorectal cancer (Table 3).
Adenoma characteristics associated with
recurrence
Patients with three or four adenomas at baseline
colonoscopy had a two-fold greater risk of recurrence
than those with one adenoma (Table 4, hazard ratio, 2.44;
95% CI, 1.11-5.35). Patients with advanced adenoma had a
two-fold greater risk than those without (hazard ratio,
2.88; 95%CI, 1.40-5.95). Although not statistically
significant, patients with a large adenoma (≥1 cm in
diameter) or a tubulovillous adenoma tended to have a
greater risk than those with a small adenoma (hazard
ratio, 1.98; 95% CI, 0.90-4.34) or a tubular adenoma
(hazard ratio, 3.57; 95% CI, 0.90-10.24). There was no
difference in recurrence rate associated with the location,
morphology, or degree of dysplasia. On multivariate
analysis, patients with three or four adenomas had a
three-fold greater risk of recurrence than those with one
Table 2. Miss rate of colorectal polyps according to polyp size
Polyp size Total
1-4 mm 5-9 mm ≥10 mm
Total number of polyps, n 134 96 20 250
Missed polyps, n 32 19 2 53
Miss rate*, % 23.9 19.8 10 21.2
*p=0.159
Figure 1. Annual recurrence rate of adenoma. The recurrence
rate was 27.5, 14.3, 12.5, 4.2, 0, and 20% in year 1-2, 2-3, 3-4, 4-
5, 5-6, and 6-7 of the follow-up period, respectively.
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Table 4. Adenoma characteristics associated with recurrence
Recurrence No recurrence Hazard ratio 95% CI
(n=30) (n=98)
No. of adenomas, n (%)
1 15 (50.0) 62 (63.3) 1.00
2 4 (13.3) 19 (19.4) 0.96 0.32-2.91
3, 4 11(36.7) 17 (17.3) 2.44 1.11-5.35
Location, n (%)
Distal colon and rectum 13 (43.3) 52 (53.1) 1.00
Proximal colon 12 (40.0) 34 (34.7) 1.25 0.57-2.76
Both* 5 (16.7) 12 (12.2) 2.00 0.70-5.67
Size, n (%)
<1.0 cm 21 (70.0) 83 (84.7) 1.00
≥1.0 cm 9 (30.0) 15 (15.3) 1.98 0.90-4.34
Histology, n (%)
Tubular 22 (88) 92 (95.8) 1.00
Tubulovillous 3 (12) 4 (4.2) 3.57 0.90-10.24
Advanced adenoma, n (%)
No 17 (56.7) 81 (82.7) 1.00
Yes 13 (43.3) 17 (17.3) 2.88 1.40-5.95
Dysplasia, n (%)
Mild 14 (50.5) 62 (63.9) 1.00
Moderate 8 (28.6) 27 (27.8) 1.19 0.50-2.86
Severe, adenocarcinoma 6 (20) 8 (8.2) 1.37 0.38-4.87
Configuration, n (%)
Protruded 28 (93.3) 90 (91.8) 1.00
Superficial 2 (6.7) 8 (8.2) 0.53 0.12-2.44
CI, confidence interval.
*Adenomas in both the distal colon and rectum and proximal colon. 
Table 3. Patient characteristics associated with recurrence
Recurrence No recurrence Hazard ratio 95% CI
(n=30) (n=98)
Age, n (%)
<60 16 (53.3) 74 (75.5) 1.00
≥60 14 (46.7) 24 (24.5) 2.39 1.16-4.90
Sex, n (%)
Male 17 (56.7) 49 (50) 1.08 0.52-2.26
Female 13 (43.3) 49 (50) 1.00
Family history*, n (%)
No 30 (100) 95 (96.9)
Yes 0 3 (3.1)
CI, confidence interval.
*Family history of colorectal cancer in a parent or sibling200 The Korean Journal of Internal Medicine Vol. 24, No. 3, September 2009
Table 5. Multivariate logistic regression for adenoma
recurrence
Hazard ratio* 95% CI
No. of adenomas
1 1.00
2 1.24 0.33-4.63
3, 4 3.19 1.04-9.79
Location
Distal colon and rectum 1.00
Proximal colon 1.62 0.64-4.12
Both
† 1.41 0.36-5.47
Size
<1.0 cm 1.00
≥1.0 cm 0.30 0.05-2.05
Histology
Tubular 1.00
Tubulovillous 0.88 0.18-4.31
Advanced adenoma
No 1.00
Yes 5.00 0.71-35.28
CI, confidence interval.
*Adjusting for age, sex, and other adenoma characteristics.
†Adenomas in both the distal colon and rectum and proximal
colon.
Table 6. Adenoma characteristics at baseline and
endpoint colonoscopy
Baseline adenoma  Recurrent adenoma  
(n=128) (n=30)
No. of adenomas, n (%)
1 77 (60.2) 27 (90)*
2 23 (18) 2 (6.7)
3, 4 28 (21.9) 1 (3.3)
Location, n (%)
Distal colon 65 (50.8) 16 (53.3)
Proximal colon 46 (35.9) 12 (40.0)
Both colon
† 17 (13.3) 2 (6.7)
Size, n (%)
<1.0 cm 104 (81.2) 25 (86.2)
≥1.0 cm 24 (18.8) 4 (13.4)
Histology, n (%)
Tubular 114 (94.2) 30 (100)
Tubulovillous 7 (5.8) 0 (0)
Advanced adenoma, n (%)
No 98 (76.6) 26 (86.7)
Yes 30 (23.4) 4 (13.3)
*p=0.001 compared with baseline adenoma.
†Adenomas in both the distal colon and rectum and proximal
colon.
Figure 2. The cumulative adenoma recurrence rate according to the number of adenomas and presence of advanced
adenoma. (A) Patients with three or four adenomas at baseline colonoscopy had a greater recurrence rate than those with
one adenoma. (B) Patients with an advanced adenoma had greater recurrence than those without.
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adenoma (hazard ratio, 3.19; 95% CI, 1.04-9.79). No other
variable had a significant effect (Table 5). Figure 2
summarizes the cumulative adenoma recurrence rate
according to the number of adenomas and presence of
advanced adenoma.
Characteristics of baseline and recurrent adenomas
Compared to the baseline adenomas, most recurrent
adenomas consisted of a single lesion (p=0.001) and all of
them were tubular adenomas on pathology (Table 6). 
DISCUSSION
The adenoma carcinoma sequence is a slow, multistep
process, and only a small proportion of adenomas,
approximately 3 to 5%, develops into carcinoma after 10
years [10]. Colonoscopy studies have observed colorectal
adenomas in 40% of the population over 50 years of age
[11,12]. Primary prevention of colorectal cancer is limited
because the causes of this ailment are unclear. Secondary
or tertiary prevention, i.e., the removal of precancerous
lesions or early cancers, may be more useful for reducing
mortality due to colorectal cancer.
Most observational studies have revealed a substantial
reduction in the risk of colorectal cancer after adenoma
removal. However, patients with removed adenomas are
recommended to undergo repeat colonoscopy due to the
high risk of recurrence. With the cost and complications of
colonoscopy, the main challenges are to formulate
guidelines for follow-up duration and define the groups of
patients who need intense follow-up [6].
The main problem with recurrence studies lies in the
high miss rate of polyps during colonoscopy, which leads
to falsely high recurrence rates. Most studies of adenoma
recurrence have reported recurrence rates and risk factors
without considering the colonoscopic miss rate. There is
evidence that the miss rate is higher in cases with multiple
polyps, small polyps, or polyps in the right colon [7,8]. In a
meta-analysis of 465 patients in 6 studies by van Rijn et al.
[9], the estimated overall miss rate was 22%: 26% in
patients with 1-5 mm polyps, 13% for 5-9 mm polyps, and
2.1% for polyps larger than 10 mm.
In the present study, to reduce the miss rate, we excluded
patients with five or more polyps and performed a follow-
up colonoscopy within 2 months to identify and remove
missed polyps. The reported miss rate is higher in cases
with multiple polyps [8]. This tendency was also seen in
our study when multiplicity was limited to less than five
polyps. We excluded patients with five or more polyps to
reduce the miss rate because missed adenomas may be
considered recurrent ones, even though we recognize that
this exclusion creates a slight selection bias that somewhat
limits the study results. The mean follow-up period was
35.1 months (range 12-84) and the recurrence rate was
23.4%, which was generally lower than the 22-50%
reported in previous studies [6,13-23]. We believe that this
resulted from correcting the recurrence rate by lowering
the miss rate by follow-up colonoscopy performed within
2 months.
Although re-examination at a short interval is not
performed in routine clinical practice, the institutional
ethics committee approved the method, as it was recognized
as essential to the purpose of this study.
When to undergo a follow-up colonoscopy after remov-
ing an adenoma is controversial. Follow-up colonoscopy
in patients with 1 or 2 small (<1 cm) resected adenomas is
recommended in 5-10 years, depending on the institute.
Follow-up colonoscopy in patients with multiple adenomas
or an advanced adenoma is recommended within 3 years
in most institutes [24-26]. According to the annual
recurrence rates in our study, most recurrent adenomas
developed within 3 years and all four advanced adenomas
did so within 3 years. Hence, in our opinion, follow-up
colonoscopy should be performed within 3 years.
Predictors of colorectal adenoma recurrence have not
been well established. The reported risk factors for
recurrence include multiple adenomas [6,13-23], a large
adenoma [17,19,20,22], severe dysplasia [13,20], a
tubulovillous/villous adenoma [13,20,23], and an
adenoma in the proximal colon [6,14]. In our study, the
recurrence of colorectal adenoma was significantly greater
in patients with three or four adenomas and advanced
adenoma. Although not statistically significant, patients
with a large adenoma (≥10 mm in diameter) or a
tubulovillous adenoma tended to have a greater risk of
recurrence. As this study examined relatively few cases,
other characteristics of polyps, such as size or histology,
may not have reached statistical significance. On multi-
variate analysis, patients with three or four adenomas had
a three-fold greater risk of recurrence. Therefore, the
presence of multiple adenomas independently predicts
the recurrence of adenoma.
Some studies have reported that recurrent adenomas
tended to be multiple, small, tubular, and in the proximal
colon compared with the baseline adenomas [14]. In202 The Korean Journal of Internal Medicine Vol. 24, No. 3, September 2009
contrast, we found that all recurrent adenomas had a
tubular architecture and most were single lesions. There
was no difference in the size or location of the recurrent
adenomas. Perhaps the reason why most recurrent
adenomas were single lesions is that the missed polyps
were identified at follow-up colonoscopy performed
within 2 months.
In conclusion, the recurrence rate of colorectal adenoma
corrected by lowering the miss rate (i.e., 23.4%) was lower
than that in most previous reports. We found that the
presence of multiple adenomas at baseline colonoscopy
was an important predictor of the recurrence of colorectal
adenoma. Therefore, a more careful follow-up examination
should be performed in patients with multiple adenomas
at baseline colonoscopy. 
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